Qiagen NV (QGEN)
42.78
+0.45
(+1.06%)
USD |
NYSE |
Nov 22, 16:00
42.79
+0.01
(+0.02%)
After-Hours: 20:00
Qiagen Price to Book Value: 2.694 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 22, 2024 | 2.694 |
November 21, 2024 | 2.665 |
November 20, 2024 | 2.650 |
November 19, 2024 | 2.569 |
November 18, 2024 | 2.581 |
November 15, 2024 | 2.598 |
November 14, 2024 | 2.650 |
November 13, 2024 | 2.684 |
November 12, 2024 | 2.722 |
November 11, 2024 | 2.774 |
November 08, 2024 | 2.755 |
November 07, 2024 | 2.780 |
November 06, 2024 | 2.762 |
November 05, 2024 | 2.767 |
November 04, 2024 | 2.748 |
November 01, 2024 | 2.712 |
October 31, 2024 | 2.651 |
October 30, 2024 | 2.660 |
October 29, 2024 | 2.634 |
October 28, 2024 | 2.632 |
October 25, 2024 | 2.616 |
October 24, 2024 | 2.619 |
October 23, 2024 | 2.652 |
October 22, 2024 | 2.658 |
October 21, 2024 | 2.652 |
Date | Value |
---|---|
October 18, 2024 | 2.707 |
October 17, 2024 | 2.688 |
October 16, 2024 | 2.721 |
October 15, 2024 | 2.763 |
October 14, 2024 | 2.776 |
October 11, 2024 | 2.765 |
October 10, 2024 | 2.725 |
October 09, 2024 | 2.799 |
October 08, 2024 | 2.743 |
October 07, 2024 | 2.728 |
October 04, 2024 | 2.743 |
October 03, 2024 | 2.741 |
October 02, 2024 | 2.792 |
October 01, 2024 | 2.828 |
September 30, 2024 | 2.869 |
September 27, 2024 | 2.953 |
September 26, 2024 | 2.938 |
September 25, 2024 | 2.879 |
September 24, 2024 | 2.928 |
September 23, 2024 | 2.902 |
September 20, 2024 | 2.930 |
September 19, 2024 | 2.975 |
September 18, 2024 | 2.981 |
September 17, 2024 | 2.98 |
September 16, 2024 | 3.039 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.196
Minimum
Oct 30 2023
4.619
Maximum
Oct 09 2020
3.383
Average
3.289
Median
Price to Book Value Benchmarks
LENZ Therapeutics Inc | 4.535 |
Oruka Therapeutics Inc | 2.140 |
Boston Scientific Corp | 6.406 |
Merus NV | 4.428 |
uniQure NV | 5.047 |
Price to Book Value Related Metrics
PE Ratio | 105.21 |
PS Ratio | 4.763 |
Price to Free Cash Flow | 20.38 |
Price | 42.78 |
Earnings Yield | 0.95% |
Market Cap | 9.508B |
Operating PE Ratio | 51.96 |
Normalized PE Ratio | 57.29 |